UK trial has found that azathioprine does not slow progression in early Parkinson’s disease, despite good tolerability. The ...

This therapy is one of a few drugs in mid-to-late-stage development for Parkinson’s that has displayed disease-modifying ...

A jarring new study has revealed that Parkinson’s disease cases worldwide are on track to more than double over the next three decades, highlighting an urgent need for greater awareness and earlier ...

Parkinson's disease is often seen as a condition that primarily affects older adults. In reality, it can impact people at any age, with 10-20% of cases appearing before the age of 50, and about half ...

While celebrities like Michael J. Fox and Brett Favre have been open about their struggles with Parkinson’s disease, it can present differently in everyone. Because of this, it’s harder to identify ...

For decades, Parkinson’s disease has been framed as a simple story of dwindling dopamine, a slow erosion of the brain’s ...

ST. PAUL, Minn., April 11 (UPI) --Israeli researchers said Friday they have developed a simple, "revolutionary" blood test that for the first time would allow doctors to detect the onset of ...

AC Immune reports Phase 2 data showing stabilized Parkinson's biomarkers, strong antibody response, and a potential slowing of disease progression in early-stage patients.

The earlier Parkinson's disease is spotted, the better – for patients, their loved ones, and scientists working toward treatments or a cure. Now, a new study has found that volatile organic compounds ...

We've already seen a pen that helps people with Parkinson's disease to write clearly, but this one is a little different. By assessing its user's hand movements as they write, it can provide an early ...

In a magical scene towards the end of the 2007 film Ratatouille, notoriously harsh food critic Anton Ego is instantly ...